Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite

NCT04190654 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Kyowa Kirin, Inc.